Viewing Study NCT00563758


Ignite Creation Date: 2025-12-25 @ 12:19 AM
Ignite Modification Date: 2026-01-19 @ 11:47 AM
Study NCT ID: NCT00563758
Status: TERMINATED
Last Update Posted: 2011-06-16
First Post: 2007-08-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy, Safety and Tolerability of Tegaserod 2 mg Bid vs Placebo in Patients With Chronic Constipation
Sponsor: Hospital Authority, Hong Kong
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Constipation View
None Chronic Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic constipation View